119 related articles for article (PubMed ID: 7053252)
1. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides.
Tirelli U; Carbone A; Veronesi A; Galligioni E; Trovò MG; Tumolo S; Grigoletto E
Cancer Treat Rep; 1982 Jan; 66(1):167-9. PubMed ID: 7053252
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.
Grozea PN; Jones SE; McKelvey EM; Coltman CA; Fisher R; Haskins CL
Cancer Treat Rep; 1979 Apr; 63(4):647-53. PubMed ID: 87277
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Groth O; Hellbe L; Holst R; Knudsen EA; Roupe G; Schmidt H
Acta Derm Venereol; 1980; 60(6):542-4. PubMed ID: 6162347
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy for mycosis fungoides with cyclophosphamide, vincristine, methotrexate, and prednisone.
Case DC
Am J Clin Oncol; 1984 Oct; 7(5):453-5. PubMed ID: 6507366
[TBL] [Abstract][Full Text] [Related]
5. Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis fungoides.
Zachariae H; Grunnet E; Thestrup-Pedersen K; Molin L; Schmidt H; Starfelt F; Thomsen K
Acta Derm Venereol; 1982; 62(2):162-4. PubMed ID: 6179344
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience.
Zachariae H; Thestrup-Pedersen K
Acta Derm Venereol; 1987; 67(5):433-7. PubMed ID: 2448996
[TBL] [Abstract][Full Text] [Related]
7. Mycosis fungoides bullosa.
Natsuga K; Shimizu T; Abe R; Kodama K; Shimizu H
Arch Dermatol; 2006 Jun; 142(6):793-5. PubMed ID: 16785397
[No Abstract] [Full Text] [Related]
8. Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hallberg O; Hellbe L
Acta Derm Venereol; 1979; 59(1):84-7. PubMed ID: 84480
[TBL] [Abstract][Full Text] [Related]
9. Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients.
Sentis HJ; Willemze R; Van Vloten WA
Acta Derm Venereol; 1985; 65(2):179-83. PubMed ID: 2408428
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.
Mishima Y; Nagasaki E; Terui Y; Irie T; Takahashi S; Ito Y; Oguchi M; Kawabata K; Kamata S; Hatake K
Cancer; 2004 Sep; 101(6):1437-44. PubMed ID: 15368332
[TBL] [Abstract][Full Text] [Related]
11. [Primary cutaneous lymphoma--mycosis fungoides].
Nagatani T; Okazawa H; Mizuno H; Yanagi N; Miyazawa M; Baba N
Gan To Kagaku Ryoho; 1997 Jan; 24(1):23-9. PubMed ID: 9020941
[TBL] [Abstract][Full Text] [Related]
12. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
Marcus R; Imrie K; Solal-Celigny P; Catalano JV; Dmoszynska A; Raposo JC; Offner FC; Gomez-Codina J; Belch A; Cunningham D; Wassner-Fritsch E; Stein G
J Clin Oncol; 2008 Oct; 26(28):4579-86. PubMed ID: 18662969
[TBL] [Abstract][Full Text] [Related]
13. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
[TBL] [Abstract][Full Text] [Related]
14. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
16. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Zinzani PL; Stefoni V; Musuraca G; Tani M; Alinari L; Gabriele A; Marchi E; Pileri S; Baccarani M
Cancer; 2004 May; 100(10):2190-4. PubMed ID: 15139063
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous lymphoma in Tunisia: clinical profile and therapeutic results].
Maalej M; Frikha H; Daoud J; Sellami D; Ben Romdhane K; Kamoun MR; Souissi R; Ben Osmen A; Zahaf A; Nouira R; Bouaouina N; Ben Abdallah M
Cancer Radiother; 1998; 2(4):404-7. PubMed ID: 9755755
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia.
Oken MM; Kaplan ME
Cancer Treat Rep; 1979 Mar; 63(3):441-7. PubMed ID: 371799
[No Abstract] [Full Text] [Related]
20. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
